Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), alter disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), alter disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
701
-
702
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
703
-
704
-
705
-
706
Demographic characteristics of the breast cancer patients enrolled in the study.
Published 2025Subjects: -
707
-
708
-
709
-
710
-
711
The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH).
Published 2025Subjects: -
712
-
713
The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status.
Published 2025Subjects: -
714
Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects.
Published 2025Subjects: -
715
The clinicopathological information of the patients involved in this study.
Published 2025Subjects: -
716
-
717
Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.
Published 2025Subjects: -
718
Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.
Published 2025Subjects: -
719
-
720